DNA encoding biosynthetic binding protein for cancer marker
AssigneesChiron Corporation, Creative BioMoelcules, Inc.
InventorsJames S. Huston, L. L. Houston, David B. Ring, Hermann Oppermann
Life of this patent
Estimating the term…
Abstract
Disclosed is DNA encoding a single-chain Fv (sFv) polypeptide defining a binding site which exhibits the immunological binding properties of an immunoglobulin molecule which binds c-erbB-2 or a c-erbB-2-related tumor antigen, the sFv includes at least two polypeptide domains connected by a polypeptide linker spanning the distance between the C-terminus of one domain and the N-terminus of the other, the amino acid sequence of each of the polypeptide domains includes a set of complementarity determining regions (CDRs) interposed between a set of framework regions (FRs), the CDRs conferring immunological binding to the c-erbB-2 or c-erbB-2-related tumor antigen.
Claims3
A DNA molecule comprising nucleotide residue numbers 1-729 of SEQ ID NO:
- 3.
Dependencies are inferred from the claim text.